Suzanne is an NHMRC Career Development Fellow. Her research has led to a greater understanding of how to identify and respond to prescription and over-the-counter drug-related problems. She's informed legislative change in Australia to reduce pharmaceutical drug harm, expanded overdose prevention with naloxone in primary care settings, and informed clinical guidelines on the use of opioid agonist treatment for prescribed opioids dependence.
Her current research focuses on understanding how to improve identification of prescribed opioid use disorder, with the aim of reducing risks relating to prescribed opioid use through evidence-based treatment and prevention.
Suzanne Nielsen's Articles
Dispelling the myths
Melbourne is set to get its second safe injecting facility, but objections to them continue to overshadow the enormous public health gains made.
Regulating opioid supply
New rules aim to curb opioid-related deaths in Australia. These changes are a step in the right direction, but we need to tread carefully to avoid unintended consequences.
Avoiding a deadly double
Maintaining or expanding addiction services is vital if we’re to avert a syndemic of opioid overdoses and COVID-19.
Treating opioid dependence
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioids – where to from here?
Opioids are among the most powerful analgesics available to medicine, but they have huge capacity to cause harm. In trying to solve one problem, is a bigger one being created?